Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

EXPRESS: Long term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics.

White RJ, Parikh K, Allen R, Feldman J, Jerjez-Sanchez C, Pan L, Keogh AM, Vizza CD, Shapiro SM, Gordon K, Broderick M, Bartolome S.

Pulm Circ. 2019 Jul 10:2045894019866335. doi: 10.1177/2045894019866335. [Epub ahead of print] No abstract available.

PMID:
31290359
2.

Life-Saving Combined Heart-Kidney Transplantation in a Previous Sequential Heart and Kidney Transplant Recipient.

Sharma M, Anthony C, Hayward C, Jabbour A, Keogh AM, Macdonald P, Sevastos J.

Eur J Case Rep Intern Med. 2018 Aug 28;5(8):000924. doi: 10.12890/2018_000924. eCollection 2018.

3.

Longitudinal immunosuppression data can minimize misclassification bias in solid organ transplantation cohorts.

Laaksonen MA, Webster AC, McCaughan GW, Keogh AM, Grulich AE, Vajdic CM.

Clin Transplant. 2019 Feb;33(2):e13470. doi: 10.1111/ctr.13470. Epub 2019 Jan 20.

PMID:
30586213
4.

Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.

Hoeper MM, Benza RL, Corris P, de Perrot M, Fadel E, Keogh AM, Kühn C, Savale L, Klepetko W.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801906. doi: 10.1183/13993003.01906-2018. Print 2019 Jan.

5.

A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy.

Horvat C, Johnson R, Lam L, Munro J, Mazzarotto F, Roberts AM, Herman DS, Parfenov M, Haghighi A, McDonough B, DePalma SR, Keogh AM, Macdonald PS, Hayward CS, Roberts A, Barton PJR, Felkin LE, Giannoulatou E, Cook SA, Seidman JG, Seidman CE, Fatkin D.

Genet Med. 2019 Jan;21(1):133-143. doi: 10.1038/s41436-018-0036-2. Epub 2018 Jun 11.

PMID:
29892087
6.

Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure.

Kumarasinghe G, Jain P, Jabbour A, Lai J, Keogh AM, Kotlyar E, Jansz P, Macdonald PS, Hayward CS.

ESC Heart Fail. 2018 Aug;5(4):695-702. doi: 10.1002/ehf2.12284. Epub 2018 Mar 24.

7.

Comparison of hemodynamic parameters in treatment-naïve and pre-treated patients with pulmonary arterial hypertension in the randomized phase III PATENT-1 study.

Galiè N, Grimminger F, Grünig E, Hoeper MM, Humbert M, Jing ZC, Keogh AM, Langleben D, Rubin LJ, Fritsch A, Davie N, Ghofrani HA.

J Heart Lung Transplant. 2017 May;36(5):509-519. doi: 10.1016/j.healun.2016.12.012. Epub 2016 Dec 24.

8.

Iatrogenic immunosuppression and risk of non-Hodgkin lymphoma in solid organ transplantation: A population-based cohort study in Australia.

Na R, Laaksonen MA, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM.

Br J Haematol. 2016 Aug;174(4):550-62. doi: 10.1111/bjh.14083. Epub 2016 May 2.

PMID:
27136044
9.

Long-term biventricular HeartWare ventricular assist device support--Case series of right atrial and right ventricular implantation outcomes.

Shehab S, Macdonald PS, Keogh AM, Kotlyar E, Jabbour A, Robson D, Newton PJ, Rao S, Wang L, Allida S, Connellan M, Granger E, Dhital K, Spratt P, Jansz PC, Hayward CS.

J Heart Lung Transplant. 2016 Apr;35(4):466-73. doi: 10.1016/j.healun.2015.12.001. Epub 2015 Dec 9.

PMID:
26849954
10.

High azathioprine dose and lip cancer risk in liver, heart, and lung transplant recipients: A population-based cohort study.

Na R, Laaksonen MA, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM.

J Am Acad Dermatol. 2016 Jun;74(6):1144-1152.e6. doi: 10.1016/j.jaad.2015.12.044. Epub 2016 Jan 30.

PMID:
26830865
11.

Impact of left ventricular assist device speed adjustment on exercise tolerance and markers of wall stress.

Hayward CS, Salamonsen R, Keogh AM, Woodard J, Ayre P, Prichard R, Kotlyar E, Macdonald PS, Jansz P, Spratt P.

Int J Artif Organs. 2015 Sep;38(9):501-7. doi: 10.5301/ijao.5000431. Epub 2015 Sep 16.

PMID:
26391365
12.

Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.

Kumarasinghe G, Lavee O, Parker A, Nivison-Smith I, Milliken S, Dodds A, Joseph J, Fay K, Ma DD, Malouf M, Plit M, Havryk A, Keogh AM, Hayward CS, Kotlyar E, Jabbour A, Glanville AR, Macdonald PS, Moore JJ.

J Heart Lung Transplant. 2015 Nov;34(11):1406-14. doi: 10.1016/j.healun.2015.05.021. Epub 2015 Jun 11.

PMID:
26279197
13.

Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.

Na R, Laaksonen MA, Grulich AE, Webster AC, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM.

Clin Transplant. 2015 Nov;29(11):978-90. doi: 10.1111/ctr.12617. Epub 2015 Sep 24.

PMID:
26278925
14.

Impact of Implantable Cardioverter Defibrillators on Survival of Patients with Centrifugal Left Ventricular Assist Devices.

Lee W, Tay A, Subbiah RN, Walker BD, Kuchar DL, Muthiah K, Macdonald PS, Keogh AM, Kotlyar E, Jabbour A, Spratt P, Jansz PC, Granger E, Dhital K, Hayward CS.

Pacing Clin Electrophysiol. 2015 Aug;38(8):925-33. doi: 10.1111/pace.12654. Epub 2015 May 31.

PMID:
25940215
15.

Potential role of coenzyme Q10 in facilitating recovery from statin-induced rhabdomyolysis.

Wang LW, Jabbour A, Hayward CS, Furlong TJ, Girgis L, Macdonald PS, Keogh AM.

Intern Med J. 2015 Apr;45(4):451-3. doi: 10.1111/imj.12712.

PMID:
25827512
16.

Effect of exercise and pump speed modulation on invasive hemodynamics in patients with centrifugal continuous-flow left ventricular assist devices.

Muthiah K, Robson D, Prichard R, Walker R, Gupta S, Keogh AM, Macdonald PS, Woodard J, Kotlyar E, Dhital K, Granger E, Jansz P, Spratt P, Hayward CS.

J Heart Lung Transplant. 2015 Apr;34(4):522-9. doi: 10.1016/j.healun.2014.11.004. Epub 2014 Nov 8.

PMID:
25662859
17.

Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease.

Roberts AM, Ware JS, Herman DS, Schafer S, Baksi J, Bick AG, Buchan RJ, Walsh R, John S, Wilkinson S, Mazzarotto F, Felkin LE, Gong S, MacArthur JA, Cunningham F, Flannick J, Gabriel SB, Altshuler DM, Macdonald PS, Heinig M, Keogh AM, Hayward CS, Banner NR, Pennell DJ, O'Regan DP, San TR, de Marvao A, Dawes TJ, Gulati A, Birks EJ, Yacoub MH, Radke M, Gotthardt M, Wilson JG, O'Donnell CJ, Prasad SK, Barton PJ, Fatkin D, Hubner N, Seidman JG, Seidman CE, Cook SA.

Sci Transl Med. 2015 Jan 14;7(270):270ra6. doi: 10.1126/scitranslmed.3010134.

18.

Modified Potts shunt in an adult with pulmonary arterial hypertension and recurrent syncope - three-year follow-up.

Keogh AM, Nicholls M, Shaw M, Dhital K, Weintraub R, Winlaw DS.

Int J Cardiol. 2015 Mar 1;182:36-7. doi: 10.1016/j.ijcard.2015.01.009. Epub 2015 Jan 5. No abstract available.

PMID:
25576730
19.

Six-minute walk distance predicts VO₂ (max) in patients supported with continuous flow left ventricular assist devices.

Prichard RA, Juul M, Gazibarich G, Davidson PM, Mason C, Keogh AM, Macdonald PS, Hayward CS.

Int J Artif Organs. 2014 Jul 31;37(7):539-45. doi: 10.5301/ijao.5000345. Epub 2014 Jul 18.

PMID:
25044385
20.

Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy.

Gupta S, Woldendorp K, Muthiah K, Robson D, Prichard R, Macdonald PS, Keogh AM, Kotlyar E, Jabbour A, Dhital K, Granger E, Spratt P, Jansz P, Hayward CS.

Heart Lung Circ. 2014 Oct;23(10):963-9. doi: 10.1016/j.hlc.2014.04.259. Epub 2014 Jun 3.

PMID:
24973864
21.

Percutaneous interventional therapies for the treatment of patients with severe pulmonary hypertension.

Bhamra-Ariza P, Keogh AM, Muller DWM.

J Am Coll Cardiol. 2014 Feb 25;63(7):611-618. doi: 10.1016/j.jacc.2013.11.022. Epub 2013 Dec 11. Review.

22.

Increased incidence of angiodysplasia of the gastrointestinal tract and bleeding in patients with continuous flow left ventricular assist devices (LVADs).

Muthiah K, Robson D, Macdonald PS, Keogh AM, Kotlyar E, Granger E, Dhital K, Spratt P, Hayward CS.

Int J Artif Organs. 2013 Jul;36(7):449-54. doi: 10.5301/ijao.5000224. Epub 2013 May 20.

PMID:
23897227
23.

Riociguat for the treatment of pulmonary arterial hypertension.

Ghofrani HA, Galiè N, Grimminger F, Grünig E, Humbert M, Jing ZC, Keogh AM, Langleben D, Kilama MO, Fritsch A, Neuser D, Rubin LJ; PATENT-1 Study Group.

N Engl J Med. 2013 Jul 25;369(4):330-40. doi: 10.1056/NEJMoa1209655.

24.

Death on an LVAD-Two sides of a coin.

Phan JA, Muthiah K, Robson D, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Dhital K, Granger E, Jansz P, Hayward CS.

Heart Lung Circ. 2013 Nov;22(11):952-4. doi: 10.1016/j.hlc.2013.02.001. Epub 2013 Mar 16.

PMID:
23506725
25.

Interaction between physical activity and continuous-flow left ventricular assist device function in outpatients.

Hu SX, Keogh AM, Macdonald PS, Kotlyar E, Robson D, Harkess M, Granger E, Dhital K, Jansz P, Spratt P, Hayward CS.

J Card Fail. 2013 Mar;19(3):169-75. doi: 10.1016/j.cardfail.2013.01.008.

PMID:
23482077
26.

De novo cancer-related death in Australian liver and cardiothoracic transplant recipients.

Na R, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM.

Am J Transplant. 2013 May;13(5):1296-304. doi: 10.1111/ajt.12192. Epub 2013 Mar 6.

27.

Centrifugal continuous-flow left ventricular assist device in patients with hypertrophic cardiomyopathy: a case series.

Muthiah K, Phan J, Robson D, Macdonald PS, Keogh AM, Kotlyar E, Granger E, Dhital K, Spratt P, Jansz P, Hayward CS.

ASAIO J. 2013 Mar-Apr;59(2):183-7. doi: 10.1097/MAT.0b013e318286018d.

PMID:
23438784
28.

Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.

Muthiah K, Robson D, Macdonald PS, Keogh AM, Kotlyar E, Granger E, Dhital K, Spratt P, Jansz P, Hayward CS.

Artif Organs. 2013 Mar;37(3):313-8. doi: 10.1111/j.1525-1594.2012.01567.x. Epub 2013 Feb 4.

PMID:
23373528
29.

Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients.

Na R, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM.

Am J Transplant. 2013 Jan;13(1):174-83. doi: 10.1111/j.1600-6143.2012.04302.x. Epub 2012 Oct 24.

30.

Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.

Tapson VF, Torres F, Kermeen F, Keogh AM, Allen RP, Frantz RP, Badesch DB, Frost AE, Shapiro SM, Laliberte K, Sigman J, Arneson C, Galiè N.

Chest. 2012 Dec;142(6):1383-1390. doi: 10.1378/chest.11-2212.

PMID:
22628490
31.

Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial.

Zuckermann A, Wang SS, Ross H, Frigerio M, Eisen HJ, Bara C, Hoefer D, Cotrufo M, Dong G, Junge G, Keogh AM.

J Transplant. 2011;2011:535983. doi: 10.1155/2011/535983. Epub 2011 Sep 13.

32.

Effect of alteration in pump speed on pump output and left ventricular filling with continuous-flow left ventricular assist device.

Hayward CS, Salamonsen R, Keogh AM, Woodard J, Ayre P, Prichard R, Walker R, Kotlyar E, Macdonald PS, Jansz P, Spratt P.

ASAIO J. 2011 Nov-Dec;57(6):495-500. doi: 10.1097/MAT.0b013e318233b112.

PMID:
21989420
33.

A randomised, placebo-controlled trial of carvedilol in early familial dilated cardiomyopathy.

Yeoh T, Hayward C, Benson V, Sheu A, Richmond Z, Feneley MP, Keogh AM, Macdonald P, Fatkin D.

Heart Lung Circ. 2011 Sep;20(9):566-73. doi: 10.1016/j.hlc.2011.06.004. Epub 2011 Jul 16.

PMID:
21763198
34.

Overweight and obesity among older adults on admission to hospital.

Lithander FE, Keogh AM, Killeen L.

Ir Med J. 2011 Mar;104(3):87-8.

PMID:
21667614
35.

Evaluation of left ventricular enlargement as a marker of early disease in familial dilated cardiomyopathy.

Fatkin D, Yeoh T, Hayward CS, Benson V, Sheu A, Richmond Z, Feneley MP, Keogh AM, Macdonald PS.

Circ Cardiovasc Genet. 2011 Aug 1;4(4):342-8. doi: 10.1161/CIRCGENETICS.110.958918. Epub 2011 Jun 2.

PMID:
21636824
36.

Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.

Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Jansz P, Hayward CS.

J Heart Lung Transplant. 2011 Aug;30(8):888-95. doi: 10.1016/j.healun.2011.03.006. Epub 2011 Apr 29.

PMID:
21530314
37.

Usefulness of extracorporeal membrane oxygenation for early cardiac allograft dysfunction.

Listijono DR, Watson A, Pye R, Keogh AM, Kotlyar E, Spratt P, Granger E, Dhital K, Jansz P, Macdonald PS, Hayward CS.

J Heart Lung Transplant. 2011 Jul;30(7):783-9. doi: 10.1016/j.healun.2011.01.728. Epub 2011 Apr 9.

PMID:
21481606
38.

Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses.

Jabbour A, Hayward CS, Keogh AM, Kotlyar E, McCrohon JA, England JF, Amor R, Liu X, Li XY, Zhou MD, Graham RM, Macdonald PS.

Eur J Heart Fail. 2011 Jan;13(1):83-92. doi: 10.1093/eurjhf/hfq152. Epub 2010 Sep 1.

39.

Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.

Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.

J Am Coll Cardiol. 2010 Apr 27;55(17):1780-7. doi: 10.1016/j.jacc.2010.01.024.

40.

Interventional and surgical modalities of treatment in pulmonary hypertension.

Keogh AM, Mayer E, Benza RL, Corris P, Dartevelle PG, Frost AE, Kim NH, Lang IM, Pepke-Zaba J, Sandoval J.

J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S67-77. doi: 10.1016/j.jacc.2009.04.016. Review.

41.

Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension.

Keogh AM, Jabbour A, Hayward CS, Macdonald PS.

Vasc Health Risk Manag. 2008;4(5):1111-3.

42.

Everolimus-associated pneumonitis in 3 heart transplant recipients.

Otton J, Hayward CS, Keogh AM, Glanville AR, Macdonald PS.

J Heart Lung Transplant. 2009 Jan;28(1):104-6. doi: 10.1016/j.healun.2008.10.003. Epub 2008 Dec 12.

PMID:
19134540
43.

Bosentan therapy in patients with pulmonary arterial hypertension: the relationship between improvements in 6 minute walk distance and quality of life.

Strange G, Keogh AM, Williams TJ, Wlodarczyk J, McNeil KD, Gabbay E.

Respirology. 2008 Sep;13(5):674-82. doi: 10.1111/j.1440-1843.2008.01326.x.

PMID:
18713089
44.

Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.

Keogh AM, Jabbour A, Weintraub R, Brown K, Hayward CS, Macdonald PS.

J Heart Lung Transplant. 2007 Nov;26(11):1079-83. Epub 2007 Oct 24.

PMID:
18022071
45.

Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan.

Keogh AM, McNeil KD, Wlodarczyk J, Gabbay E, Williams TJ.

J Heart Lung Transplant. 2007 Feb;26(2):181-7.

PMID:
17258153
47.

Comparison and validation of three measures of quality of life in patients with pulmonary hypertension.

Chua R, Keogh AM, Byth K, O'Loughlin A.

Intern Med J. 2006 Nov;36(11):705-10.

PMID:
17040356
48.

Apparent clearance of sirolimus in heart transplant recipients: impact of primary diagnosis and serum lipids.

Zahir H, Keogh AM, Akhlaghi F.

Ther Drug Monit. 2006 Oct;28(5):614-22. Erratum in: Ther Drug Monit. 2006 Dec;28(6):817. Corrected and republished in: Ther Drug Monit. 2006 Dec;28(6):818-26.

PMID:
17038875
49.

Public funding of bosentan for the treatment of pulmonary artery hypertension in Australia: cost effectiveness and risk sharing.

Wlodarczyk JH, Cleland LG, Keogh AM, McNeil KD, Perl K, Weintraub RG, Williams TJ.

Pharmacoeconomics. 2006;24(9):903-15.

PMID:
16942124
50.

Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study.

Kobashigawa JA, Renlund DG, Gerosa G, Almenar L, Eisen HJ, Keogh AM, Lehmkuhl HB, Livi U, Ross H, Segovia J, Yonan N; ERL2401 Heart Study Investigators.

J Heart Lung Transplant. 2006 Aug;25(8):935-41. Epub 2006 Jun 27.

PMID:
16890114

Supplemental Content

Loading ...
Support Center